Mycobactenium sp. strain PYR-1, previously shown to extensively mineralize high-molecular-weight polycyclic aromatic hydrocarbons in pure culture and in sediments, degrades fluoranthene to 9-fluorenone-1-carboxylic acid. In this study, 10 other fluoranthene metabolites were isolated from ethyl acetate extracts of the culture medium by thin-layer and high-performance liquid chromatographic methods. On the basis of comparisons with authentic compounds by UV spectrophotometry and thin-layer chromatography as well as gas chromatography-mass spectral and proton nuclear magnetic resonance spectral analyses, the metabolites were identified as 8-hydroxy-7-methoxyfluoranthene, 9-hydroxyfluorene, 9-fluorenone, 1-acenaphthenone, 9-hydroxy-1-fluorenecarboxylic acid, phthalic acid, 2-carboxybenzaldehyde, benzoic acid, phenylacetic acid, and adipic acid. Authentic 9-hydroxyfluorene and 9-fluorenone were metabolized by Mycobacterium sp. strain PYR-1. A pathway for the catabolism of fluoranthene by Mycobacterium sp. strain PYR-1 is proposed.
Fluoranthene is one of the principal polycyclic aromatic hydrocarbons (PAHs) in contaminated sediments (12) . Since PAHs such as fluoranthene are increasingly widespread environmental pollutants and have been shown to be cytotoxic, mutagenic, and, in many cases, carcinogenic (4-6, 20-23, 27, 34-37) , there is considerable interest in the fate of these compounds in the environment. Although microbial metabolic pathways for the degradation of PAHs containing up to three rings have been proposed (7, 11) , until recently, little information has been available concerning the ability of microorganisms to metabolize the larger, more recalcitrant, high-molecular-weight PAHs (28) . Biotransformation of the tetracyclic PAH fluoranthene by eukaryotes has been reported previously (1, 2, 31, 32) , and bacteria that are able to oxidize or cooxidize fluoranthene have been isolated (3, 10, 13, 24, 26, 29, 30, 38, 39) .
Research in this laboratory has demonstrated the ability of Mycobacterium sp. strain PYR-1 (15-18, 25, 33) to substantially mineralize fluoranthene in pure culture (24, 26) and significantly enhance mineralization of fluoranthene in sediments containing indigenous microorganisms (24) . Recently, we reported the isolation and characterization of 9-fluorenone-1-carboxylic acid resulting from the oxidation and subsequent ring fission of fluoranthene by Mycobactenum sp. strain PYR-1 (26) . In this report, additional metabolites are identified and the possible modes of degradation of fluoranthene by Mycobacterium sp. strain PYR-1 are discussed.
MATERIALS AND METHODS Chemicals. Fluoranthene was purchased from Fluka AG, Buchs, Switzerland. 9-Hydroxyfluorene, 9-fluorenone, 9-hydroxy-1-fluorenecarboxylic acid, and 9-fluorenone-1-carboxylic acid were obtained from Aldrich Chemical Co., Milwaukee, Wis. Bacteriological media and reagents were purchased from Difco Laboratories, Detroit, Mich.; all solvents and other chemicals used were of the highest purity available.
Culture conditions. The degradation of fluoranthene by Mycobacterium sp. strain PYR-1 has been described in detail previously (24) . To monitor the disappearance of 9-fluorenone-1-carboxylic acid, 9-fluorenone, and 9-hydroxyfluorene, fluoranthene-adapted Mycobacterium cultures were incubated at 24°C in 125-ml flasks containing 30 ml of mineral salts medium with nutrients (18) UV-visible absorption spectra were determined in methanol with a Beckman model DU-7 spectrophotometer. HPLC on-line absorbance spectra were obtained by using a 1040A diode array spectrophotometer (Hewlett-Packard, Inc., Palo Alto, Calif.) attached to the above-mentioned HPLC system.
Fluoranthene metabolites for chemical and physical analyses and identification were isolated as reported previously (26) .
For gas chromatography-mass spectrometry (GC-MS) analysis, the acid-extractable residues were derivatized either by acetylation with acetic anhydride and pyridine or by methylation with diazomethane (19 (Fig. 2a) . DEP-EI mass spectral analysis of authentic 9-hydroxyfluorene produced a spectrum similar to that of metabolite II.
The 'H NMR spectrum of metabolite II is in full agreement with the structure of 9-hydroxyfluorene (Fig. 3a) . Metabolite IV had a UV absorption spectrum similar to that of fluoranthene ( Table 1 ). The R value of metabolite IV was 0.68 in benzene-ethanol (9:1). The structure of metabolite IV was determined by MS (Fig. 2b) and 'H NMR spectroscopy (Fig. 3b) . DEP-EI analysis of metabolite IV showed an apparent molecular ion [M+] The 500-MHz 'H NMR spectrum of metabolite IV consisted of eight aromatic protons and a three-proton singlet in the aliphatic region (Fig. 3b) . Decoupling experiments indicated the presence of the three aromatic ring systems of fluoranthene, with substituents at C-7 and C-8. The chemical shift of the aliphatic singlet and the lack of any small long-range couplings to the aromatic protons were consistent with the presence of a methoxyl group and in agreement with the mass spectral data. The key experiment in elucidating the site of the methoxyl group was an NOE on H-6 as a result of selective saturation of the methoxy protons. This established that the methoxyl group was attached at C-7 of the fluoranthene ring system. The large upfield shifts of 0.5 and 0.4 ppm for H-9 and H-10, respectively, compared with the data reported for fluoranthene (31) , are in good accord with ortho-andpara-substituent effects from hydroxyl and methoxyl groups. 1H NMR chemical shifts (b in parts per million) and ortho-coupling constants (J in hertz) for metabolite IV are 81, 7.91; 82, 7.62; 83, 7.81; b4, 7.88; 85, 7.68; 86, 8.13; 89, Additionally, GC-MS analysis of acetylated and methylated residues of ethyl acetate extracts of the acidified aqueous phase revealed the presence of low-molecular-weight acids, including phthalic acid (metabolite VI). The phthalic acid methyl ester had a molecular ion at an mlz of 194, with fragment ions at mlz's of 77 and 133, and a base peak at an mlz of 163 [M+ -OCH3]. Additional minor acidic compounds found in the extract were the methyl esters of phenylacetic acid (metabolite IX), benzoic acid (metabolite X), and adipic acid (metabolite VII) ( Table 1 ). The mass spectra of all of these compounds were identified by comparison to the National Institute of Standards and Technology mass spectral library.
Metabolites XI, V, and VIII were identified as 1-acenaphthenone, 2-carboxybenzaldehyde, and 9-hydroxy-1-fluorenecarboxylic acid by comparison of their GC and HPLC retention times and UV (Table 1) and mass spectra to those of authentic standards. moiety should yield 9-fluorenone, neither 9-fluorenone nor 9-fluorenol was found in those extracts because of the rapid metabolism. However, both of these compounds were present in the neutral ethyl acetate extracts from fluoranthene metabolism. When the Mycobacterium sp. was incubated with commercially available 9-fluorenone, 9-fluorenol was formed. Conversely, 9-fluorenol incubated with Mycobacterium sp. strain PYR-1 resulted in the formation of 9-fluorenone (Fig. 1 ).
DISCUSSION
The observations that 9-fluorenone-1-carboxylic acid was apparently easily metabolized and did not accumulate to significant amounts, coupled with the metabolites found in the HPLC extracts, suggest that this compound is a metabolite of one of several pathways of fluoranthene mineralization by Mycobacterium sp. strain PYR-1.
The formation of 9-fluorenone-1-carboxylic acid (26) (Fig. 4) .
Although the abiotic conversion of a 9-fluorenone to 9-hydroxyfluorene is possible in the presence of a strong nucleophile, only minimal abiotic oxidation/reduction was observed in autoclaved controls. Therefore, the reaction was catalyzed enzymatically. The possible action of a reductase is suggested because it has been reported that NADPHcytochrome P-450 reductase in the presence of NADPH was responsible for the reduction/oxidation of 9-fluorenone " 9-hydroxyfluorene by rat liver microsomes (8) . (14) . Alternatively, cytochrome P-450 monooxygenation, followed by enzymatic hydration resulting in trans-7,8-dihydro-7,8-dihydroxyfluoranthene, and subsequent dehydrogenation and methylation of the hydroxyl moiety at C-7, could result in the formation of small amounts of 7-methoxy-8-hydroxyfluoranthene (Fig. 4) . Monooxygenation is consistent with previous studies of pyrene and naphthalene degradation by Mycobactenium sp. strain PYR-1 (18, 25) , which suggest the formation of small amounts of trans-dihydrodiol metabolites from the metabolism of PAHs. Methylation of a dihydroxylated intermediate could be brought about by a catechol O-methyltransferase (9) .
The identification and isolation of metabolites that retain the intact fluorene configuration, as well as the identification of an initial oxygenated metabolite in which the single benzene ring has been attacked, indicate that several pathways operate simultaneously on the degradation of fluoranthene by Mycobactenium sp. strain PYR-1 (Fig. 4) (24) . The relatively low concentrations of metabolites, the rapid evolution of carbon dioxide, and the rapid disappearance of fluoranthene from the medium provide concrete evidence of the usefulness of this Mycobactenum sp. strain PYR-1 for bioremediation of some PAHs.
